# Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults

> **NCT01717950** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 40 (actual)

## Conditions studied

- Hookworm Infection
- Hookworm Disease

## Interventions

- **BIOLOGICAL:** Na-APR-1 (M74)/Alhydrogel®
- **BIOLOGICAL:** Gluco-Pyranosylphospho-Lipid A Aqueous Formulation

## Key facts

- **NCT ID:** NCT01717950
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01717950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01717950, "Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01717950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*